Acquisition Rumors Continue to Circulate Around Aurinia as GSK Denies Interest

GlaxoSmithKline has denied reports that they were interested in acquiring Canada’s Aurinia Pharmaceuticals. The UK’s Mail issued a statement on Sunday, October 31, claiming the UK-based pharma giant was preparing to bid on Aurinia. A GSK spokesperson told Reuters the report was not true.